Paradigm Biocapital Advisors LP Legend Biotech Corp Transaction History

Paradigm Biocapital Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $30.8 Million - $44.6 Million	-778,698 Reduced 39.29%	1,203,308 $53.3 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $4.81 Million - $6.11 Million	87,362 Added 4.61%	1,982,006 $111 Million
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $7.49 Million - $9.12 Million	-130,836 Reduced 6.46%	1,894,644 $114 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $13.9 Million - $16.8 Million	219,763 Added 12.17%	2,025,480 $136 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $13.7 Million - $22.2 Million	295,393 Added 19.56%	1,805,717 $125 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $19.8 Million - $26.1 Million	455,454 Added 43.18%	1,510,324 $72.8 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $842,774 - $1.2 Million	-21,721 Reduced 2.02%	1,054,870 $52.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $3.74 Million - $5.6 Million	97,995 Added 10.01%	1,076,591 $43.9 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $4.93 Million - $8.08 Million	146,868 Added 17.66%	978,596 $53.8 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $13.8 Million - $21.5 Million	445,761 Added 115.49%	831,728 $30.2 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $15.9 Million - $22 Million	385,967 New	385,967 $18 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.